US OptionsDetailed Quotes
RSKD241220P2500
- 0.00
- 0.000.00%
15min DelayClose Dec 13 09:30 ET
0.00High0.00Low
0.00Open0.00Pre Close0 Volume0 Open Interest2.50Strike Price0.00Turnover0.00%IV49.19%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier5DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma98.40Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Riskified Stock Discussion
Sign in to post a comment
$Riskified (RSKD.US)$
Riskified Achieves Record Quarterly Free Cash Flows; Board Authorizes Additional $75 Million Share Repurchase Program
Riskified (NYSE: RSKD) reported strong Q3 2024 results with significant improvements in financial metrics. Revenue increased 10% year-over-year to $78.8 million, while GMV grew 17% to $34.7 billion. The company achieved record quarterly free cash flow of $13.9 million and improved GAAP gross profit margin to 49%. Notable achievements include winning ...
Riskified Achieves Record Quarterly Free Cash Flows; Board Authorizes Additional $75 Million Share Repurchase Program
Riskified (NYSE: RSKD) reported strong Q3 2024 results with significant improvements in financial metrics. Revenue increased 10% year-over-year to $78.8 million, while GMV grew 17% to $34.7 billion. The company achieved record quarterly free cash flow of $13.9 million and improved GAAP gross profit margin to 49%. Notable achievements include winning ...
$Riskified (RSKD.US)$
NEWS
Riskified Achieves Record Quarterly Free Cash Flows; Board Authorizes Additional $75 Million Share Repurchase Program
NEWS
Riskified Achieves Record Quarterly Free Cash Flows; Board Authorizes Additional $75 Million Share Repurchase Program
1
Riskified's decreasing cash burn and rising revenues hint a solid growth trajectory. Various factors making its cash burn situation seem safer include cash runway, revenue growth and ability to secure additional capital.
Gainers:
In reaction to earnings/guidance:
• $The Trade Desk (TTD.US)$+17%, $Workiva (WK.US)$ +15.3%, $Arlo Technologies (ARLO.US)$ +12%, $Array Technologies (ARRY.US)$ +10.3%, $Everbridge (EVBG.US)$ +9.7%, $Catalyst Pharmaceuticals (CPRX.US)$ +9.4%, $Halozyme Therapeutics (HALO.US)$ +8.7%, $Velo3D (VLD.US)$ +7.6%, $CyberArk (CYBR.US)$ + 6.2%, $Haemonetics (HAE.US)$ +5.8%, $Jackson Financial (JXN.US)$ +5.7% (also increases dividend), $Axon Enterprise (AXON.US)$ +4.8%, ...
In reaction to earnings/guidance:
• $The Trade Desk (TTD.US)$+17%, $Workiva (WK.US)$ +15.3%, $Arlo Technologies (ARLO.US)$ +12%, $Array Technologies (ARRY.US)$ +10.3%, $Everbridge (EVBG.US)$ +9.7%, $Catalyst Pharmaceuticals (CPRX.US)$ +9.4%, $Halozyme Therapeutics (HALO.US)$ +8.7%, $Velo3D (VLD.US)$ +7.6%, $CyberArk (CYBR.US)$ + 6.2%, $Haemonetics (HAE.US)$ +5.8%, $Jackson Financial (JXN.US)$ +5.7% (also increases dividend), $Axon Enterprise (AXON.US)$ +4.8%, ...
11
3
5
CAN I AT LEAST LEAST LEATHER HOW TO BUY N SELL STOCKS ON THIS BROCHURE MOOMOO 
FOR REAL I DONT GET IT 
$Riskified (RSKD.US)$ all in, let’s go
2
2
$Riskified (RSKD.US)$ I am in
2
1
No comment yet
LukeM : Company itself is doing pretty good. I don’t think the war situation is having too big of an affect on it now a little bit yes but clearly not a lot.
74457239 LukeM : 为什么近来每天交易量那么少？